Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Bioharmony Therapeutics Inc.

Bioharmony Therapeutics, Inc. is an emerging biopharmaceutical company focused on the discovery and development of first-in-class lysin-based antimicrobial therapeutics for patients with multi-drug resistant Gram-negative bacterial infections. In addition to the Acinetobacter lysin, Bioharmony’s portfolio includes a proprietary line-up of lysins for the treatment for pneumonia, skin, urinary tract and bloodstream infections caused by Gram-negative bacterial infections such as E.coli, Klebsiella and others. *

 

Period Start 2019-01-15 existent
Products Industry antibiotic
  Industry 2 bacteriophage therapy
Person Person Ghose, Chandrabali (Bioharmony Therapeutics 201901 CEO + Founder)
     
Region Region New York, NY
  Country United States (USA)
  Street 340 East 80th Street
  City 10075 New York, NY
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: Alnylam Pharmaceuticals, Inc.. (1/14/19). "Press Release: Alnylam Pharmaceuticals Announces Proposed Public Offering of Common Stock". Cambridge, MA.
     
   
Record changed: 2019-01-23

Advertisement

Picture [iito] Made Without Love 650x80px

More documents for Bioharmony Therapeutics Inc.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px




» top